4th Boston Biotechnology Virtual Summit
September 10, 2020
The 4th Boston ● Paris Biotechnology Virtual Summit ● Focus on Covid-19 – will be held, via a zoom platform, on Thursday 15 October 2020, 11 AM – 01 PM US EDT [17:00 – 19:00 EU CET] in three sequential panels as below.
The Program Committee, listed below*, have convened renowned experts to analyze and discuss the treatment/prevention of Covid-19, as well as its impact on the biotechnology industry. Their Covid-19 expertise ranges from the “trenches” of every day clinical care to the complexity of decision making. Event held in collaboration with Mass Bio Hub.
|Panel ①: Covid-19 Prevention. Full review of vaccines and public prevention policies.|
|Panel ②: Covid-19 Treatment. Full review of treatments in clinical trials and medical care.|
|Panel ③: Finance, Investment & Leadership in the new Covid-19 era.|
|Shahin Gharakhanian, MD, DPHCo-Founder, Principal, & Program ChairShahin Gharakhanian MD Consulting LLCCIC: Cambridge Innovation CenterCambridge MA 02142, USA.|
|*2020 International Program Committee|
|Christophe Arbet-Engels, MD, PhD, MBA CMO, Millendo Therapeutics, Ann Arbor MI. CCEF: Conseiller de Commerce Extérieur de la France ● French Foreign Trade Advisor.||Nicola La Monica, PhD, Senior Director, Infectious Disease Scientific Innovation,Johnson & Johnson, Boston MA.||Frederick E. “Rick” Pierce II. CEO & President, SanaRx Tx,Principal, FEP Capital Advisors, USA & China: Cambridge MA, New York, Beijing, Shanghai.|
|Pierre Courteille, Pharm., MBA Vice-President, FRANCE-BIOTECH,CCO, Abivax. Paris, France.||Cecile Le Camus, MD, MBA, Executive Director & Medical Lead, Vertex Pharmaceuticals,Boston MA.||Heather Steinman, PhD, MBA. Vice-President for BD & Executive Director of Technology Transfer, The Wistar Institute, Philadelphia PA.|
|Mark De Rosch, PhD, FRAPS Chief Regulatory Officer,Epizyme Inc, Cambridge MA.||Imran Nasrullah, PhD, Vice President & Head, Open Innovation Center North America – East at Bayer Pharmaceuticals,Cambridge MA, USA||Milos Todorovic, PhD, Trade Commissioner – Life Sciences, Consulate General of CANADA, Boston MA.|
|Marc Filerman, CEO, GERMANY Accelerator Life Sciences, Cambridge MA.||Tibor Nemes, MBA President, Stallergenes Greer,Boston MA.||● SPECIAL ADVISOR TO ORGANIZING TEAM: Pravin Chaturvedi, PhD. CEO, Woburn MA.|
|*In alphabetical order|